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Combined Inﬂuence of Insulin
Resistance, Overweight/Obesity,
and Fatty Liver as Risk Factors for
Type 2 Diabetes
KI-CHUL SUNG, MD, PHD1
WOO-SHIN JEONG, MD1
SARAH H. WILD, MB BCHIR, PHD2
CHRISTOPHER D. BYRNE, MB BCH, PHD3
OBJECTIVEdThere is dissociation between insulin resistance, overweight/obesity, and fatty
liver as risk factors for type 2 diabetes, suggesting that different mechanisms are involved. Our
aim was to 1) quantify risk of incident diabetes at follow-up with different combinations of
these risk factors at baseline and 2) determine whether each is an independent risk factor for
diabetes.
RESEARCH DESIGNANDMETHODSdWe examined 12,853 subjects without diabe-
tes from a South Korean occupational cohort, and insulin resistance (IR) (homeostasis model
assessment-IR $75th centile, $2.0), fatty liver (deﬁned by standard ultrasound criteria), and
overweight/obesity (BMI $25 kg/m2) identiﬁed at baseline. Odds ratios (ORs) and 95% conﬁ-
dence intervals (CIs) for incident diabetes at 5-year follow-up were estimated using logistic
regression.
RESULTSdWe identiﬁed 223 incident cases of diabetes from which 26 subjects had none of
the three risk factors, 37 had one, 56 had two, and 104 had three. In the fully adjusted model, the
OR and CI for diabetes were 3.92 (2.86–5.37) for IR, 1.62 (1.17–2.24) for overweight/obesity,
and 2.42 (1.74–3.36) for fatty liver. The OR for the presence of all three factors in a fully adjusted
model was 14.13 (8.99–22.21).
CONCLUSIONSdThe clustering of IR, overweight/obesity, and fatty liver is common and
markedly increases the odds of developing type 2 diabetes, but these factors also have effects
independently of each other and of confounding factors. The data suggest that treatment for each
factor is needed to decrease risk of type 2 diabetes.
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People who develop type 2 diabetesrepresent a heterogeneous group ofindividuals, some of whom have
normal insulin sensitivity, normal weight,
and b-cell failure; others have insulin resis-
tance (IR) and inadequate compensatory
hyperinsulinemia; and others have a com-
bination of defects in both insulin sensi-
tivity and b-cell function (1,2). The
prevalence of diabetes is predicted to dou-
ble between the years 2000 and 2030 (3)
and, although an ageing population and
increasing urbanization in developing
countries will contribute to this marked
increase in prevalence (3), the predicted
prevalence is likely to be underestimated
because of the increasing global burden of
obesity. Several potential mechanisms
may explain why obesity is a strong risk
factor for diabetes (4). These mechanisms
include increased production of nones-
terﬁed fatty acids; adipokines/cytokines,
including tumor necrosis factor-a, resis-
tin, and retinol-binding protein 4; as well
as reduced levels of adiponectin and mi-
tochondrial dysfunction that compromise
b-cell function (5). Although obesity has
undoubtedly contributed to the burden of
diabetes (4) and strategies to decrease
body fat are effective in decreasing risk
of diabetes, there are several unanswered
questions regarding the mechanism(s) of
the link between obesity and diabetes (5).
IR is also a risk factor for type 2 di-
abetes (6,7) and has a close association
with obesity. Both obesity and IR are
also strongly associated with fatty liver
(8,9), and it is now evident that fatty liver
is a risk factor for type 2 diabetes (10–13).
However, fatty liver may occur in both
normal weight and overweight/obese in-
dividuals, and the precise mechanism by
which fatty liver increases risk of type 2
diabetes is uncertain. Fatty liver may af-
fect risk of diabetes via an effect on the
secretion of hepatokines (14), increased
gluconeogenesis, decreased glycogen
synthesis, and inhibition of insulin signal-
ing (15,16). Although fatty liver is associ-
ated with diabetes, not all individuals
with fatty liver have IR (17–19). Thus,
although IR, overweight/obesity, and
fatty liver are strongly correlated, there
is clear evidence of dissociation between
these three risk factors. The dissociation
between these risk factors suggests that
different pathogenetic mechanisms may
operate by which insulin resistance, over-
weight/obesity, and fatty liver contribute
to type 2 diabetes. Affected individuals
who develop type 2 diabetes may have
any one, two, or three of these risk factors,
but the impact of different combinations
of risk factors is uncertain. Establishing
the roles of the different combinations
of these risk factors may be helpful to un-
derstand the pathogenesis of type 2
diabetes and to inform approaches to pre-
vention and treatment. Using data from a
cohort study with measurements of IR,
overweight/obesity, and fatty liver at
baseline, the aim of our study was to 1)
estimate the strength of the association
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between different combinations of these
three risk factors and incident diabetes
and 2) determine whether the effects of
each factor are independent of each other
and potential confounding factors.
RESEARCH DESIGN AND
METHODS
Study subjects
The study population consisted of indi-
viduals who had a comprehensive health
examination at baseline (2003) and were
reexamined 5 years later (2008) at Kang-
buk Samsung Hospital, College of Med-
icine, Sungkyunkwan University, South
Korea. Initially 15,638 participants were
identiﬁed and 416 were excluded for
having type 2 diabetes at baseline (based
on any one or more of self-reported,
medical histories and fasting plasma glu-
cose results). Individuals with data miss-
ing at baseline for the following variables
were also excluded: plasma glucose (n = 1),
serum insulin (n = 1,346), BMI (n = 26),
alcohol consumption (n = 399), smoking
(n = 361), education (n = 581), and exercise
(n = 309). After all the exclusions, 12,853
participants were eligible for this analysis
from which 223 participants were diag-
nosed with diabetes by 2008. The study
was approved by the Institutional Review
Board at Kangbuk Samsung Hospital.
Informed consent was not required be-
cause personal identifying information
was not used.
Measurements and calculations
The health examination included full
medical histories, physical examinations,
and blood samples. BMI was calculated as
weight in kilograms divided by height in
meters squared. Questionnaires were
used to ascertain information regarding
alcohol consumption (g/day), smoking
(never, ex-, current), duration of educa-
tion (school #12 years, college 13–14
years, university.14years), and frequency
of exercise (none, less than once a week, at
least once a week).
Blood samples for laboratory exami-
nations were collected after an overnight
fast. Fasting plasma glucose, total choles-
terol, triglyceride, and HDL cholesterol
concentrations were measured using Bayer
Reagent Packs on an automated chemistry
analyzer (Advia 1650 Autoanalyzer; Bayer
Diagnostics, Leverkusen, Germany). LDL
cholesterol concentration was calculated
using the Friedwald equation. Insulin con-
centration was measured with an immu-
noradiometric assay (Biosource, Nivelle,
Belgium) with an intra- and interassay
coefﬁcient of variation of 2.1–4.5% and
4.7–12.2%, respectively. Homeostasis
model assessment (HOMA) index was
calculated by the following equation
(HOMA-IR = [fasting insulin (mIU/mL)
3 fasting glucose (mmol/L)]/22.5). Since
there are no population-speciﬁc thresh-
olds to indicate IR in a Korean population,
we stratiﬁed the populations using the 75th
centile to establish an insulin-resistant
group (HOMA-IR $75th centile), which
was compared with a more insulin-sensitive
group (HOMA-IR,75th centile). BMI$25
kg/m2 was used to deﬁne overweight/
obesity. Abdominal ultrasonography (Logic
Q700 MR; General Electric, Milwaukee,
WI) using a 3.5-MHz probe was performed
in all subjects by experienced clinical radi-
ologists, and fatty liver was diagnosed
based on standard criteria, including
hepatorenal echo contrast, liver brightness,
and vascular blurring (20).
Statistical analysis
Continuous variables were expressed as
mean 6 SD for normally distributed var-
iables or median (interquartile range) if
not normally distributed. Continuous
variables were compared using indepen-
dent t tests, non-normally distributed
variables were compared using Mann-
Whitney U tests, and categorical variables
were expressed as percentages and com-
pared between groups using the x2 test.
Characteristics at baseline were compared
between individuals who developed dia-
betes during follow-up and those remain-
ing free from diabetes at follow-up.
Comparisons between groups were also
undertaken stratiﬁed by IR (HOMA-IR
$75th centile, HOMA $2.0) and over-
weight/obesity (BMI $25 kg/m2). We
used logistic regression to determine
odds ratios (ORs) for developing diabetes
according to the presence of 1) a single
baseline risk factor of interest, i.e., insulin
resistance, overweight/obesity, fatty liver;
2) all combinations of two of these three
baseline risk factors; and 3) all three base-
line risk factors compared with the group
with none of these risk factors. Analyses
were repeated after adjustment for age,
sex, educational status, smoking status
(never, ex-, current), exercise frequency
(less than once a week or at least once a
week), alcohol consumption (g/day), ala-
nine aminotransferase (ALT), and triglycer-
ide levels. All data analysis was performed
using SPSS, version 15.0 (SPSS, Chicago,
IL). The statistical signiﬁcance of P values
in this report was set at ,0.05.
RESULTSdThere were 223 cases of in-
cident diabetes during follow-up, and the
characteristics of these individuals com-
pared with the remainder of the cohort
are shown in Table 1. The cohort was of
working age with a preponderance of men.
In the group with diabetes at follow-up,
69% of subjects had IR compared with
24% in the group remaining free from di-
abetes at follow-up (P , 0.001). In the
group with diabetes at follow-up, 69%
were overweight or obese and 68% had
fatty liver at baseline, compared with 33%
and 27%, respectively, for the group re-
maining free from diabetes (P , 0.001 for
all comparisons).
Table 2 describes the characteristics
of people in the following strata of BMI
and insulin sensitivity
1. normal weight and insulin sensitive
(Group A)
2. normal weight and insulin resistant
(Group B)
3. overweight/obese and insulin sensitive
(Group C)
4. overweight/obese and insulin resistant
(Group D)
The prevalence of fatty liver increased
incrementally across these four groups.
The proportion of people with fatty liver
in groups A, B, C, and D was 12, 29, 42,
and 68%, respectively.
We examined the association between
each of the three risk factors of interest at
baselinewith incident diabetes at follow-up
after adjustment for age, sex, educational
status, smoking, alcohol, exercise, tri-
glyceride, and ALT. Each factor was in-
dependently associated with incident
diabetes when all three were included in
the model (IR: OR 3.92 [95% CI 2.86–
5.37], P , 0.0001; overweight/obesity:
1.62 [1.17–2.24], P = 0.004; fatty liver:
2.42 [1.74–3.36], P, 0.0001).
Next we examined the numbers of
subjects (with and without incident di-
abetes) who had different combinations
of the risk factors of interest at baseline.
There are seven potential combinations
of the three risk factors of interest, and
the ORs for each of these combinations
are shown in Table 3 and are adjusted for
1) age and sex; 2) age, sex, alcohol, smok-
ing status, and exercise and educational
levels; and 3) age, sex, alcohol, smoking
status, exercise and educational levels, and
triglyceride and ALT levels. Adjustment
for the factors in the second model had
little effect but further adjustment for tri-
glyceride and ALT levels attenuated the
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ORs slightly. Of the 223 incident cases of
diabetes identiﬁed at follow-up, 26 peo-
ple had none of the risk factors of interest,
37 had one, 56 had two, and 104 had
three risk factors at baseline. In the fully
adjusted model, the OR (95% CIs) for in-
cident diabetes for the presence of all
three risk factors at baseline was 14.13
(8.99–22.21). The data in Table 3 also de-
scribe how the three factors of interest
cluster together. Among people with one
or more risk factors of interest in the
whole cohort, the largest proportion
(34%) had overweight/obesity alone com-
pared with 28% with fatty liver and 25%
with IR as single risk factors. The least
frequent combination of two risk factors,
occurring among 3% of people, was the
combination of IR and fatty liver in the
absence of overweight/obesity. All three
factors occurred together in 10% of people
in the whole cohort at baseline. In contrast,
in the group with incident diabetes, the
cluster of all three risk factors together oc-
curred in 104/223 (47%) of subjects,
whereas only 26/223 (12%) had none of
these risk factors of interest.
CONCLUSIONSdWe have quanti-
ﬁed for the ﬁrst time the powerful impact
of the combined presence of IR, over-
weight/obesity, and fatty liver on the odds
of developing diabetes. Importantly, we
have established that each of these factors
is independently associated with incident
diabetes after adjustment for the other
two risk factors and other relevant factors.
Almost half of the subjects with incident
type 2 diabetes at 5-year follow-up had
all three risk factors at baseline, but this
cluster occurred in only approximately
10% of the population that did not de-
velop diabetes. Only 12% of incident
cases of diabetes at follow-up did not
have any of these three risk factors at
baseline compared with ;47% in the
general population. Thus, the presence
of all three risk factors occurring together
was common in subjects who develop di-
abetes, emphasizing the importance and
the frequency of the clustering of these
three risk factors for type 2 diabetes.
We have shown previously that fatty
liver is a predictor of diabetes, indepen-
dently of IR (11), and others have shown
that fatty liver is a risk factor for incident
diabetes (21–23). In a study of Japanese
men of similar age to the participants in
our study, Shibata et al. (21) showed that
fatty liver at baseline was associated with
an age and BMI adjusted hazard ratio of
5.5 (95% CI [3.6–8.5], P , 0.001) for
incident diabetes at 4-year follow-up.
Our results extend the work of these au-
thors as we show that there is also an ad-
ditional strong association between fatty
liver and incident diabetes, indepen-
dently of IR, and we have quantiﬁed the
risk of having all three risk factors.
A diagnosis of fatty liver can be es-
tablished noninvasively using techniques
such as magnetic resonance spectroscopy,
computed tomography, or ultrasound but,
recently, proxy markers for nonalcoholic
fatty liver disease (e.g., the nonalcoholic
fatty liver disease–fatty liver score and
the fatty liver index that are generated
from anthropometric and biochemical
measurements) have also been found to
be associated with incident diabetes in-
dependently of potential confounding
factors (24).
Of the three risk factors of interest,
overweight/obesity had the weakest as-
sociation with incident diabetes (fully
adjusted OR for overweight/obesity alone:
1.29 [0.62–2.71]) and IR had strongest
association (fully adjustedOR for IR alone:
3.66 [1.89–7.08]). BMI provides a general
measure of obesity and does not reﬂect re-
gional fat distribution. It is possible that
measures of central obesity such as waist
circumference would have a stronger re-
lationship with diabetes than BMI, but un-
fortunately waist measurements were not
available for all cohort participants. TheOR
for incident diabetes was highest for the
combination of IR, overweight/obesity,
and fatty liver (fully adjusted OR 14.13
[8.99–22.2]). Tests for interaction (data
not shown but available from authors)
showed no statistically signiﬁcant superad-
ditive or synergistic association of the three
factors with incident diabetes, but this may
reﬂect the limited power of the study to
detect statistically signiﬁcant interactions.
Although the most frequent combi-
nation of risk factors among subjects that
Table 1dBaseline characteristics in individuals with and without incident diabetes at
follow-up
No diabetes at
follow-up
Diabetes at
follow-up P
n 12,630 223
Age (years) 40.9 6 6.03 42.8 6 5.93 ,0.001
Men (%) 9,013 (71) 198 (89) ,0.001
Systolic BP (mmHg) 114.6 6 13.3 122.8 6 15.0 ,0.001
Diastolic BP (mmHg) 74.5 6 9.9 80.2 6 10.6 ,0.001
BMI (kg/m2) 23.8 6 2.83 26.7 6 3.26 ,0.001
Waist circumference (cm) 82.7 6 9.08 (n = 2,682) 90.1 6 7.30 (n = 50) ,0.001
Glucose (mmol/L) 5.15 6 0.46 6.05 6 0.49 ,0.001
LDL cholesterol (mmol/L) 3.07 6 0.76 3.26 6 0.73 ,0.001
HDL cholesterol (mmol/L) 1.37 [1.21–1.58] 1.27 [1.14–1.45] ,0.001
TC (mmol/L) 5.33 6 0.91 5.61 6 0.93 ,0.001
TG (mmol/L) 1.32 [0.94–1.89] 2.07 [1.42–2.79] ,0.001
Insulin (pmol/L) 46.3 [37.5–59.5] 63.1 [46.8–79.7] ,0.001
HOMA-IR 1.52 [1.21–1.99] 2.41 [1.83–3.02] ,0.001
Alcohol (g/day) 10.8 6 15.1 15.6 6 19.6 ,0.001
Smoking status
Nonsmoker 6,344 (50) 71 (32) ,0.001
Ex-smoker 2,476 (20) 52 (23)
Current smoker 3,811 (30) 100 (45)
Education status (years)
#12 3,060 (24) 62 (28) 0.017
13–14 1,111 (8.8) 27 (12)
.14 8,460 (67) 134 (60)
Physical activity
None 3,601 (29) 51 (23) 0.068
,1 time/week 4,573 (36) 96 (43)
IR 3,059 (24) 154 (69) ,0.001
Overweight/obesity 4,191 (33) 155 (69) ,0.001
Fatty liver 3,403 (27) 152 (68) ,0.001
Data are mean6 SD, median [interquartile range] for continuous variables, or n (%) for categorical variables.
BP, blood pressure; TC, total cholesterol; TG, triglyceride.
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developed diabetes was the presence of all
three factors, 56/223 (25%) had only two
of the three risk factors. Of the different
possible combinations of two risk factors,
the data suggested that the combination
of overweight/obesity and fatty liver (in
the absence of IR) was associated with the
lowest odds of diabetes (OR 3.23 [95%CI
1.78–5.89]) and the combination of IR
and fatty liver had the strongest associa-
tion with diabetes (6.73 [3.49–12.73]),
although CIs are wide and overlap for
these estimates. Fatty liver is emerging
as an independent risk factor for diabetes,
and our data suggest that its association
with incident diabetes may be stronger
than that of overweight/obesity andweaker
than that of IR. However, regardless of the
relative strengths of these risk factors for
diabetes, there was a striking and marked
increase in odds of diabetes with the oc-
currence of all three risk factors. The fact
that they all have independent effects of
each other suggests that targeted speciﬁc
approaches to ameliorating the effects of
each individual risk factor may have a
considerable impact on decreasing risk
of diabetes.
In support of the notion that IR,
obesity, and fatty liver each act via differ-
ent mechanisms to increase risk of di-
abetes, it has been shown recently that
combined metformin and rosiglitazone
treatment has discordant effects on cen-
tral obesity, hepatic IR, and fatty liver
(25). These investigators showed that
although the rosiglitazone and metformin
combination had no effect on central obe-
sity, the combination has a transient effect
on hepatic insulin sensitivity and a sus-
tained effect on ALT (as a proxy marker
for fatty liver). Overweight/obesity may
increase fat accumulation in key insulin-
sensitive tissues such as liver (26) and
when fat accumulation occurs in liver,
hepatic IR occurs via mechanisms that
increase gluconeogenesis, decrease gly-
cogen synthesis, and inhibit insulin sig-
naling (15,16). Physical inactivity is
associated with hepatic IR (27) andmodest
increases in physical activity have recently
been shown to be very effective in im-
proving liver enzymes (28) and decreas-
ing liver fat (29–33). It is likely that
Table 2dBaseline characteristics stratiﬁed by overweight/obesity and IR
HOMA centile,
,75th centile,
or $75th centile
Normal weight Overweight/Obese
Group A Group B
P
Group C Group D
PNot insulin resistant Insulin resistant Not insulin resistant Insulin resistant
N 7,174 1,333 2,466 1,880
Age (years) 40.6 6 5.99 40.5 6 6.26 0.48 41.7 6 5.91 41.6 6 6.05 0.62
SBP (mmHg) 112.1 6 12.4 114.4 6 13.5 ,0.001 118.0 6 13.0 120.9 6 14.4 ,0.001
DBP (mmHg) 72.7 6 9.3 73.9 6 9.7 ,0.001 77.4 6 9.8 79.0 6 10.4 ,0.001
Glucose (mmol/L) 5.05 6 0.44 5.38 6 0.46 ,0.001 5.18 6 0.45 5.46 6 0.49 ,0.001
LDL (mmol/L) 2.95 6 0.74 3.04 6 0.76 ,0.001 3.25 6 0.75 3.31 6 0.77 0.007
HDL (mmol/L) 1.42 [1.24–1.6] 1.38 [1.19–1.58] ,0.001 1.32 [1.18–1.50] 1.28 [1.14–1.43] ,0.001
TC (mmol/L) 5.18 6 0.88 5.34 6 0.94 ,0.001 5.55 6 0.90 5.63 6 0.91 0.003
TG (mmol/L) 1.13 [0.84–1.6] 1.39 [0.97–2.04] ,0.001 1.58 [1.14–2.19] 1.93 [1.41–2.63] ,0.001
Insulin (pmol/L) 40.6 [34.4–47.9] 67.6 [62.9–75.4] ,0.001 45.1 [38.7–51.8] 71.5 [64.7–82.7] ,0.001
HOMA-IR 1.32 [1.10–1.50] 2.30 [2.13–2.59] ,0.001 1.50 [1.28–1.75] 2.47 [2.20–2.87] ,0.001
BMI (kg/m2) 22.2 6 1.86 22.9 6 1.67 ,0.001 26.6 6 1.39 27.4 6 1.95 ,0.001
Fatty liver 850 (12) 388 (29) ,0.001 1,032 (42) 1,285 (68) ,0.001
Data are mean6 SD, median [interquartile range] for continuous variables, or n (%) for categorical variables. DBP, diastolic blood pressure; HDL, HDL cholesterol;
LDL, LDL cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.
Table 3dOR for incident diabetes at follow-up for different combinations of IR, overweight/obesity, and fatty liver
n/proportions with
incident diabetes (%)
OR [95% CI] P
Model 1 Model 2 Model 3
Whole cohort 223/12,853 (1.7)
No risk factors 26/6,324 (0.4) 1 1 1
IR alone 14/945 (1.5) 3.95 [2.05–7.61] ,0.001 4.06 [2.10–7.82] ,0.001 3.66 [1.89–7.08] ,0.001
Overweight/obesity alone 10/1,434 (0.7) 1.46 [0.70–3.05] 0.310 1.39 [0.67–2.90] 0.382 1.29 [0.62–2.71] 0.50
Fatty liver alone 13/850 (1.5) 3.28 [1.67–6.44] ,0.001 3.36 [1.71–6.60] ,0.001 2.73 [1.38–5.41] 0.004
IR and overweight/obesity 21/595 (3.5) 7.78 [4.33–13.96] ,0.001 7.51 [4.18–13.50] ,0.001 6.16 [3.38–11.22] ,0.001
IR and fatty liver 15/388 (3.9) 8.42 [4.40–16.09] ,0.001 8.73 [4.56–16.71] ,0.001 6.73 [3.49–12.97] ,0.001
Overweight/obesity
and fatty liver 20/1,032 (1.9) 4.07 [2.25–7.38] ,0.001 4.03 [2.22–7.30] ,0.001 3.23 [1.78–5.89] ,0.001
IR, overweight/obesity,
and fatty liver 104/1,285 (8.1) 18.27 [11.72–28.46] ,0.001 18.27 [12.00–29.21] ,0.001 14.13 [8.99–22.2] ,0.001
Model 1 adjusted for age and sex. Model 2 adjusted for age, sex, alcohol, smoking status, exercise, and educational status. Model 3 adjusted for age, sex, alcohol,
smoking status, exercise, educational status, triglyceride, and ALT.
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relatively small increases in physical ac-
tivity levels may decrease risk of type 2
diabetes in middle-aged individuals, not
only through accepted improvements in
improved glucose utilization and the
promotion of weight loss, but also
via a beneﬁcial impact on liver fat and
hepatic insulin sensitivity. Thus, the
marked beneﬁt on diabetes risk of in-
creases in physical activity may be act-
ing favorably to modify each of the three
major risk factors that we have investi-
gated in the current study.
Our study has some limitations. We
have used routine clinical data from an
occupational cohort with a preponder-
ance of men. Although ultrasonography
is a reasonably accurate technique for de-
tecting modest amounts of liver fat (.30%
liver fat inﬁltration), ultrasound has lim-
ited sensitivity to detect minor amounts of
fatty inﬁltration. Oral glucose tolerance
tests were not performed so subjects
with isolated 2-h postchallenge hypergly-
cemia at follow-up have been identiﬁed.
Data were not available on family history
of diabetes, participants’ lifetime exposure
to alcohol, or use of drugs known to be
associated with increased risk of diabetes
(although heavy alcohol consumption
and use of drugs of interest is likely to
be present only in a small percentage of
people in this middle-aged occupational
cohort). Data on waist circumference and
inﬂammatory markers were incomplete
(only available on approximately 18% of
the cohort), and therefore wewere unable
to use these data. Additionally, we only had
basic self-reported information on physical
activity levels in this cohort, and conse-
quently it is likely that estimates are
highly likely to be subject to measure-
ment error. The study is limited to one
ethnic group, and the distribution of risk
factors and their association with diabetes
may differ by ethnic group. Our study
was not large enough to investigate
whether the identiﬁcation of fatty liver
provides a valuable addition to diabetes
risk scores to improve risk prediction of
diabetes, and further research in several
populations is required to address this
important issue.
In conclusion, in a middle-aged oc-
cupational cohort study, we have shown
that IR, overweight/obesity, and fatty liver
commonly occur together and that each is
independently associated with increased
odds of developing type 2 diabetes. We
have quantiﬁed the cumulative impact of
different combinations of IR, overweight/
obesity, and fatty liver, and shown that
the occurrence of all three risk factors to-
gether markedly increases the risk of de-
veloping diabetes. Further research is
needed to understand the separate path-
ogenetic mechanisms by which IR, over-
weight/obesity, and fatty liver contribute
individually to the development of type 2
diabetes. It is also necessary to identify
whether effectiveness of lifestyle and
pharmaceutical interventions vary for
people with different combinations of
risk factors.
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